Please login to the form below

Not currently logged in
Email:
Password:

rectal cancer

This page shows the latest rectal cancer news and features for those working in and with pharma, biotech and healthcare.

IBM teams up with Teva for global eHealth collaboration

IBM teams up with Teva for global eHealth collaboration

Willalso partner with ICON on cancer trials project.  . IBM has signed deals with Teva and ICON that will see the firms use services based on its Watson supercomputer. ... This will be applied to breast, lung, colon and rectal cancer trials and aims to

Latest news

  • Valeant and Shire said to be evaluating potential Salix bids Valeant and Shire said to be evaluating potential Salix bids

    Valeant currently in final stages of Provenge acquisition.  . Valeant Pharmaceuticals is in the final stages of acquiring Dendreon's cancer vaccine Provenge but is already lining up its next acquisition prospect, ... Nevertheless, in the latter half of

  • Close but no cigar

    Despite failure to show clinical benefit, gene therapy continues to offer hope for cancer treatment. ... TNFerade has also shown potential in the treatment of rectal cancer, head and neck cancer, metastatic melanoma and oesophageal cancer.

  • Roche and Pfizer report growth

    Sales of the osteoporosis drug Bonviva, and the cancer therapy Avastin, which were up 41 per cent and 37 per cent respectively, contributed to the successful sales story to date. ... cancer). US revenue has decreased by 13 per cent. However, the

  • Contraceptive pill may protect against cancer

    In the main dataset women on the pill had statistically significant lower rates of large bowel/rectal, uterine body and ovarian cancer. ... The GP dataset also showed a reduced risk of uterine and ovarian cancer.

  • Feverish activity

    Erbitux (cetuximab), originally developed by ImClone Systems, and licensed to Bristol-Myers Squibb and Merck KGaA, was approved for the treatment of colo-rectal cancer in 2004 and is currently undergoing ... Treatment of advanced prostate cancer. EU.

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics